Pictet Asset Management’s Aurinia Pharmaceuticals AUPH Stock Holding History

Pictet Asset Management’s Portfolio AUPH Stock Details AUPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$265K	Hold	15,604	–	–	﹤0.01%	1831
2026 Q1	$231K	Hold	15,604	–	–	﹤0.01%	1875
2025 Q4	$249K	Buy	15,604 +3,189	+26%	+$45.2K	﹤0.01%	1805
2025 Q3	$137K	Hold	12,415	–	–	﹤0.01%	1947
2025 Q2	$105K	Hold	12,415	–	–	﹤0.01%	1933
2025 Q1	$99.8K	Hold	12,415	–	–	﹤0.01%	1929
2024 Q4	$111K	Hold	12,415	–	–	﹤0.01%	1967
2024 Q3	$91K	Hold	12,415	–	–	﹤0.01%	1950
2024 Q2	$70.9K	Hold	12,415	–	–	﹤0.01%	1924
2024 Q1	$62.2K	Hold	12,415	–	–	﹤0.01%	1929
2023 Q4	$112K	Hold	12,415	–	–	﹤0.01%	1861
2023 Q3	$96.5K	Buy	+12,415	New	+$121K	﹤0.01%	1837

Other funds holding AUPH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JAM

Jupiter Asset Management London, United Kingdom $20.2B AUM 29.18% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

RWM

Ritholtz Wealth Management New York $6.7B AUM 32.7% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

NFG

Norris Financial Group Greenville, South Carolina $251M AUM 48.4% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Pictet Asset Management's AUPH Position: Q2 2026 in Review

Pictet Asset Management held its Aurinia Pharmaceuticals (AUPH) position steady in Q2 2026 at 15,604 shares worth $265K. The position accounts for ﹤0.01% of the portfolio, ranked #1831.

Pictet Asset Management first reported a position in AUPH in Q3 2023 and has held it in 12 quarters since. 124 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

Pictet Asset Management held 15,604 shares of Aurinia Pharmaceuticals worth $265K as of Q2 2026.
Pictet Asset Management left its Aurinia Pharmaceuticals share count unchanged in Q2 2026.
Aurinia Pharmaceuticals made up ﹤0.01% of Pictet Asset Management's portfolio in Q2 2026, its #1831 holding.
Pictet Asset Management first reported a position in Aurinia Pharmaceuticals in Q3 2023 and has held it in 12 quarters since.
124 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on Pictet Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.